Swiss-based drugmaker Actelion Ltd (ATLN.VX) had offered to buy U.S. biotech company ZS Pharma Inc (ZSPH.O) last month in a deal valued at $2.5 billion, Bloomberg reported, citing people with knowledge of the matter said.
It was unclear how ZS Pharma responded to the offer or if the two companies had held discussions, Bloomberg reported. (bloom.bg/1XQC5AR)
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle12
15:14 Russia central bank: hackers stole over 2 billion roubles from accounts in central bank11
14:45 Spain raises taxes to try to meet EU deficit target12
14:36 U.S. economy added 178,000 jobs in November; unemployment rate dropped to 4.6 percent13